Can Birth Control Cause High Cholesterol?

Hormonal birth control can shift your cholesterol and triglyceride levels, but the direction and size of those shifts depend heavily on the specific formulation you use. Combined oral contraceptives, the most widely studied type, tend to raise triglycerides and can nudge LDL cholesterol up while sometimes also raising HDL, the “good” cholesterol. The net effect ranges from slightly favorable to mildly unfavorable depending on which estrogen and progestin are in the pill. And in most cases, the changes reverse once you stop.

How Hormonal Contraceptives Alter Blood Lipids

The estrogen and progestin in hormonal contraceptives pull your lipid profile in different directions, and the final result is a tug-of-war between the two. Estrogen stimulates the liver to produce more triglyceride-rich particles, while also slowing the clearance of those particles from the bloodstream. That combination reliably pushes triglycerides up in most users of oral contraceptives containing ethinyl estradiol, the synthetic estrogen in the vast majority of pills.¹ Estrogen also suppresses an enzyme called hepatic lipase, which has the effect of raising HDL cholesterol and shifting it toward a more protective form.²

Progestins work the other way. The more androgenic (testosterone-like) a progestin is, the more it stimulates hepatic lipase, undoing estrogen’s HDL-boosting effect and potentially pushing HDL down. In one head-to-head comparison, levonorgestrel, a strongly androgenic progestin, reduced HDL cholesterol by about 17% and increased hepatic lipase activity by 56%. A less androgenic progestin, medroxyprogesterone acetate, produced none of those changes.³ So the type of progestin in your pill matters as much as whether it contains estrogen at all.

What Combined Pills Actually Do to Your Numbers

A large study of healthy adolescents in Austria illustrates the typical pattern. After adjusting for other factors, pill users had total cholesterol around 180 mg/dL compared with about 162 mg/dL in nonusers. LDL cholesterol was roughly 106 versus 95 mg/dL, and triglycerides were about 104 versus 67 mg/dL. HDL cholesterol showed no meaningful difference between the two groups.⁴ Among those who started the pill during the study period, LDL rose by about 15 mg/dL more than it did in nonusers, and triglycerides climbed by about 36 mg/dL more.

But those are averages across many formulations. When researchers have tested specific pills side by side, the differences are striking. In a landmark trial comparing six different formulations, triglycerides rose by anywhere from 13% to 75% compared with controls. LDL cholesterol actually fell by 12–14% with desogestrel-containing and low-dose norethindrone pills. HDL cholesterol dropped by 5% with a low-dose levonorgestrel pill and by 16% with a high-dose levonorgestrel pill, yet it increased by 10–12% with norethindrone and desogestrel formulations.⁵ The practical takeaway: “the pill” is not one thing. A pill with a newer, less androgenic progestin can produce a very different lipid picture than one with an older, more androgenic progestin.

Even with estrogen’s triglyceride-raising effect, the body compensates in some ways. Research using isotope-tracing techniques found that while one combined pill boosted the liver’s production of LDL particles by about 50%, it also sped up the rate at which those particles were cleared from the bloodstream by about 36%, leaving overall LDL levels essentially unchanged.⁶ Triglycerides did still rise modestly, and the LDL particles became enriched with triglycerides, which some researchers consider a marker of a less favorable metabolic state even when the LDL count stays steady.

Why the Type of Estrogen Matters

Most combined pills use ethinyl estradiol, a potent synthetic estrogen. Newer formulations have started substituting estradiol valerate or 17β-estradiol, which are closer to the estrogen your body naturally produces. This swap makes a measurable difference for lipids. In a randomized trial, women on a pill containing ethinyl estradiol plus dienogest had larger increases in both HDL and triglycerides compared with those on estradiol valerate plus dienogest, which had a much milder effect on triglycerides.⁷ Another trial comparing a pill with nomegestrol acetate and 17β-estradiol against one with levonorgestrel and ethinyl estradiol found that the natural estradiol pill left lipids essentially unchanged, while the ethinyl estradiol pill lowered HDL and slightly raised LDL and triglycerides.⁸

This makes sense biologically. Oral ethinyl estradiol gets processed by the liver in a way that strongly stimulates triglyceride production. Transdermal estradiol preparations, which bypass the liver on first pass, do not increase triglycerides the same way.⁹ Natural estradiol pills are metabolized more gently by the liver than ethinyl estradiol, landing somewhere between the synthetic oral version and a patch in terms of lipid impact.

Progestin-Only Methods and Injectables

Progestin-only methods generally have a smaller effect on lipids than combined pills, but the picture is not perfectly clean. A cross-sectional study of women on various hormonal contraceptives in Ethiopia found that users had total cholesterol about 13 mg/dL higher, triglycerides about 10 mg/dL higher, and LDL roughly 9 mg/dL higher than nonusers, with no significant difference in HDL.¹⁰ That study included users of both combined and progestin-only methods, so the elevations are likely driven more by the combined pill users in the group.

Injectable depot medroxyprogesterone acetate, commonly known by its brand name Depo-Provera, causes a distinctive pattern. HDL cholesterol typically dips during the first six months of use, but then gradually climbs back to baseline by about 36 months. The LDL-to-HDL ratio follows the same arc, worsening early and then normalizing.¹¹ This early dip and recovery is something to be aware of if you get your lipids checked during the first year on the shot, because the results may not reflect the long-term picture.

Hormonal IUDs and the Vaginal Ring

The levonorgestrel-releasing IUD releases progestin directly into the uterus, with much less entering the general circulation compared with pills or injections. One randomized trial found a marginally significant reduction in total cholesterol among IUD users, along with a small dip in HDL at six months that reverted to baseline by one year. Triglycerides and LDL stayed stable throughout.¹² A larger metabolomics study found that current IUD users actually had lower levels of cholesterol, triglycerides, and various lipid particles compared with non-users of hormonal contraception, though the differences were modest.¹³ The bottom line is that the hormonal IUD has a much gentler lipid footprint than oral pills.

The contraceptive vaginal ring, which delivers ethinyl estradiol and etonogestrel, also performs differently from oral pills containing levonorgestrel. In a direct comparison, the ring did not lower HDL the way the pill did, and LDL actually decreased after three cycles of ring use while it increased with the oral pill. Both the ring and the pill raised triglycerides, but the ring’s overall profile was more favorable.¹⁴ This likely reflects the lower androgenicity of etonogestrel and differences in how hormones reach the liver when absorbed vaginally versus swallowed.

Do the Changes Reverse When You Stop?

Yes. The lipid changes caused by hormonal contraceptives appear to be reversible. A study published in Circulation found that past use of oral contraceptives had no lingering effect on triglycerides, total cholesterol, or HDL, indicating that the shifts fully unwound after discontinuation.¹⁵ The adolescent study from Austria confirmed this in a younger population: those who stopped the pill during follow-up saw their LDL and triglyceride trajectories converge back toward nonuser levels.⁴ If you are getting bloodwork done and want to know your “true” baseline lipids, keep in mind that the numbers you see while on the pill may be shifted upward by the medication.

What About Heart Disease Risk?

Unfavorable lipid changes are one thing. Whether those changes translate into actual cardiovascular events over a lifetime is a separate question, and the answer is less clear-cut. One study found that low-dose pills raised cholesterol, triglycerides, and LDL in otherwise healthy women but did not alter levels of homocysteine or nitric oxide, two markers tied to blood vessel damage, leading the authors to conclude the pills may not increase cardiovascular risk in healthy women.¹⁶ A broader review in the Journal of the American College of Cardiology described the data on whether oral contraceptives protect against or promote atherosclerosis as “mixed,” noting that longer-term follow-up with better subgroup data is needed.¹⁷

Part of the reason the picture is murky is that the lipid changes are relatively modest in absolute terms for most healthy women, and other contraceptive-related cardiovascular risks like blood clots or elevated blood pressure are often the bigger clinical concern. Oral contraceptive users also tend to have higher apolipoprotein B levels, a marker some cardiologists now consider more informative than LDL cholesterol for predicting heart disease.¹⁸ Whether those apoB elevations carry clinical weight in premenopausal women on contraceptives is an area that still lacks definitive long-term data.

Women with PCOS

Polycystic ovary syndrome already involves insulin resistance and often unfavorable lipid profiles, so the question of how the pill interacts with PCOS lipids is a practical one. In adolescents with PCOS treated with combined pills, total cholesterol and LDL rose significantly, but so did HDL and apolipoprotein A-I, and the ratios of LDL to HDL stayed unchanged.¹⁹ A longer-term study following women with PCOS over 36 cycles found elevated triglycerides and total cholesterol compared with controls, but also higher HDL and reduced LDL-to-HDL ratios.²⁰ The pill’s anti-androgenic effects in PCOS can counterbalance some of the lipid harm, since lowering excess androgens tends to help HDL. The overall balance looks acceptable for most women with PCOS, though triglyceride monitoring is worth keeping up.

If You Already Have High Cholesterol

Women with known dyslipidemia are understandably cautious about starting a combined pill. A systematic review on this topic found limited evidence: in one cohort study, only about a quarter of women who started the pill with elevated total cholesterol saw their levels normalize after six cycles, and a similar fraction of those with high triglycerides saw improvement.²¹ The evidence base here is frustratingly thin. Most clinical guidelines classify combined hormonal contraceptives as acceptable for women with mild dyslipidemia but recommend against them when triglycerides are severely elevated, because estrogen can push already-high triglycerides into a range that risks pancreatitis.

If you have existing lipid issues and want birth control with the least impact on cholesterol, the copper IUD is the cleanest option. Studies comparing copper IUD users with controls found no difference in any lipid parameter, which makes sense because the copper IUD releases no hormones at all.²² The hormonal IUD is also a reasonable choice given its minimal systemic absorption, and progestin-only pills tend to cause smaller lipid shifts than combined pills.

Genetics and Individual Variation

Not everyone’s lipids respond to contraceptives the same way, and part of that variation is genetic. Research on the apolipoprotein E gene, which plays a central role in how the body handles cholesterol-carrying particles, found a significant interaction between genetic variants and pill use. Women carrying the ε4 variant showed smaller lipid changes on the pill compared with those carrying the ε2 or ε3/ε3 variants.²³ This is still early-stage knowledge and nowhere near useful for clinical decision-making, but it helps explain why two women on the same pill can see noticeably different cholesterol responses. If you have a strong family history of high cholesterol or early heart disease, it is worth checking your lipid panel a few months after starting a new hormonal contraceptive to see how your body specifically reacts.

Timing Your Lipid Panel

One genuinely practical point that gets overlooked: if you are on hormonal birth control and get a routine cholesterol screening, the results reflect your on-contraceptive state, not necessarily your underlying risk. A total cholesterol reading of 200 mg/dL might be 180 mg/dL without the pill. Whether screening should even be done before prescribing oral contraceptives has been debated. One study used standard clinical cutoffs for dyslipidemia, defining abnormal as total cholesterol at or above 200 mg/dL, HDL below 40 mg/dL, triglycerides above 150 mg/dL, or LDL at or above 160 mg/dL.²⁴ The broader clinical consensus is that routine lipid screening is not required before prescribing combined contraceptives in young, healthy women, but it becomes more important when other risk factors like obesity, smoking, family history of premature cardiovascular disease, or diabetes are present.

If you are already monitoring your cholesterol for other reasons, mention your contraceptive method to your doctor so they can interpret the numbers in context. And if you switch from a pill to a non-hormonal method and see your cholesterol drop at your next checkup, that is likely the contraceptive effect unwinding, not a sign that your lifestyle changes suddenly paid off.